Jun 25, 2009
Arthritis Therapy Area Pipeline Report Published Date : 16 March 2009 Pages : 205 Autoimmune Diseases Therapy Area Pipeline Report contains detailed information on the autoimmune diseases drug pipeline.
Jun 25, 2009
Allergy Therapy Area Pipeline Report , Published Date : 16 March 2009, Pages : 822 Allergy Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline.
Jun 24, 2009
Access to Hospital Pharmaceutical Markets in the United Kingdom Published Date : August 2008, Pages : 81 Public hospitals represent a very important market segment for most biopharmaceutical companies in Europe.
Jun 24, 2009
Pharmacy Liberalisation in Europe: Prospects and Implications PublishedDate:September 2008,Pages : 76 Very little in the pricing environment in Europe is predictable to pharmaceutical companies and only rarely is much notice given of change.
Jun 24, 2009
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues Published Date : April 2008, Pages : 105 Eight years earlier, EU Regulation 141/2000 was enacted to encourage R&D in rare diseases and increase orphan drug output.
Jun 24, 2009
Published Date : June 2008, Pages : 110 ,Virtually no new prescription brand can be introduced without a yakka (reimbursement price) set by the government.
Jun 24, 2009
Published Date : June 2009, Author : Donald Macarthur Pages : 80 Earlier in 2009, with strong bipartisan support, Senator Bryon Dorgan (D-ND) re-tabled a bill to allow both personal and commercial drug importation.
Jun 24, 2009
Published Date : 10 April 2009, Author : Donald Macarthur, Pages : 107 GBP£ 850 - PDF PPRS and NICE, are among abbreviations most widely recognised, but their structures, functions and ways of working are often less than fully understood.
Jun 24, 2009
Published Date : April 2009 Pages : 107 ‘Complete Guide to the 2009 PPRS, NICE & other Pharmaceutical Cost Containment Measures in the UK’ delivers what it says in the title.
Jun 24, 2009
Wound Care Markets, 4th. Edition, Vol. I: Skin Ulcers Published Date : 1 March 2009 Pages : 150 The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention.